|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Net sales (Note 2 and Note 13) | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general, and administrative expenses (Note 13) | |||||
| Income from operations (Note 13) | |||||
| Interest income | |||||
| Interest expense | |||||
| Other (income) expense, net | |||||
| Total other income, net | |||||
| Income before income taxes | |||||
| Income tax expense (Note 5) | |||||
| Net income | |||||
| Other comprehensive income (loss), net of tax | |||||
| Unrealized gain on cash flow hedges | |||||
| Foreign currency translation gain (loss) | |||||
| Total other comprehensive income (loss), net of tax | |||||
| Comprehensive income | |||||
| Net income per share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average common shares outstanding (Note 12) | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
